The involvement of astrocytes and kynurenine pathway in Alzheimer's disease

被引:40
|
作者
Ting, Ka Ka [1 ,3 ]
Brew, Bruce [2 ]
Guillemin, Gilles [1 ,3 ]
机构
[1] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia
[3] Univ New S Wales, Dept Pharmacol, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
astrocyte; kynurenine pathway; Alzheimer's disease; neuroinflammation;
D O I
10.1007/BF03033908
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The kynurenine pathway (KP) and several of its neuroactive products, especially quinolinic acid (QUIN), are considered to be involved in the neuropathogenesis of Alzheimer's disease (AD). There is growing evidence suggesting that astrocytes play a critical role in the regulation of the excitotoxicity and inflammatory processes that occur during the evolution of AD. This review focuses on the role of astrocytes through their relation with the KP to the different features associated with AD including cytokine, chemokine and, adhesion molecule production, cytoskeletal changes, astrogliosis, excitotoxicity, apoptosis and neurodegeneration.
引用
收藏
页码:247 / 262
页数:16
相关论文
共 50 条
  • [1] The involvement of astrocytes and kynurenine pathway in Alzheimer’s disease
    Ka Ka Ting
    Bruce Brew
    Gilles Guillemin
    Neurotoxicity Research, 2007, 12 : 247 - 262
  • [2] INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE
    Guillemin, G. J.
    Rahman, A.
    Ting, K.
    Cullen, K. M.
    Braidy, N.
    Chung, R. S.
    Wu, W.
    Brew, B. J.
    JOURNAL OF NEUROCHEMISTRY, 2010, 115 : 39 - 39
  • [3] Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation
    Garcez, Michelle L.
    Jacobs, Kelly R.
    Guillemin, Gilles J.
    NEUROTOXICITY RESEARCH, 2019, 36 (02) : 424 - 436
  • [4] Microbiota Alterations in Alzheimer’s Disease: Involvement of the Kynurenine Pathway and Inflammation
    Michelle L. Garcez
    Kelly R. Jacobs
    Gilles J. Guillemin
    Neurotoxicity Research, 2019, 36 : 424 - 436
  • [5] Kynurenine Pathway Metabolites in Alzheimer's Disease
    Giil, Lasse Melvaer
    Midttun, Oivind
    Refsum, Helga
    Ulvik, Arve
    Advani, Rajiv
    Smith, A. David
    Ueland, Per Magne
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 495 - 504
  • [6] Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
    Lim, Chai K.
    Fernandez-Gomez, Francisco J.
    Braidy, Nady
    Estrada, Cristina
    Costa, Cristina
    Costa, Silvia
    Bessede, Alban
    Fernandez-Villalba, Emiliano
    Zinger, Anna
    Trinidad Herrero, Maria
    Guillemin, Gilles J.
    PROGRESS IN NEUROBIOLOGY, 2017, 155 : 76 - 95
  • [7] Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease
    Liang, Yuqing
    Xie, Shan
    He, Yanyun
    Xu, Manru
    Qiao, Xi
    Zhu, Yue
    Wu, Wenbin
    DISEASE MARKERS, 2022, 2022
  • [8] The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
    Zinger, Anna
    Barcia, Carlos
    Trinidad Herrero, Maria
    Guillemin, Gilles J.
    PARKINSONS DISEASE, 2011, 2011
  • [9] Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
    Guillemin, GJ
    Brew, BJ
    REDOX REPORT, 2002, 7 (04) : 199 - 206
  • [10] The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer's Disease
    Malagon, Enoc Mariano Cortes
    Ornelas, Adolfo Lopez
    Gomez, Irlanda Olvera
    Delgado, Jose Bonilla
    BRAIN SCIENCES, 2024, 14 (09)